Skip to main content

Anorexia

1
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alliance Pharmaceuticals
1 program
1
creatine monohydratePhase 31 trial
Active Trials
NCT00081250Completed300Est. Jul 2017
Bristol Myers Squibb
1 program
Megestrol acetatePHASE_33 trials
Active Trials
NCT00002067Completed
NCT00002345Completed40
NCT00002300Completed

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alliance Pharmaceuticalscreatine monohydrate

Clinical Trials (4)

Total enrollment: 340 patients across 4 trials

The Safety and Effectiveness of Megace in HIV-Infected Women

40 patients
Phase 4Completed

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

Phase 3Completed

Creatine in Treating Patients With Cancer-Associated Weight Loss

Start: Dec 2004Est. completion: Jul 2017300 patients
Phase 3Completed

A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition

Phase 2Completed

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.